Among these regulators, vir-like m6A methyltransferase associated (VIRMA), a “writer” of m6A regulators, promotes the progression of cancer and is associated with shorter survival for patients with multiple types of cancer, such as kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, and papillary thyroid carcinoma (Zhu et al., 2021). Here, VIRMA is linked to cancer.